The National Prescribing Centre (NPC) has published MeReC Extra 35 (PDF).
This MeReC covers some of key recommendations from the updated NICE guideline on type 2 diabetes. It includes a discussion in the following areas:
- HbA1c targets
- Some risks and benefits of intensive glucose lowering therapy
- Appropriate use of self monitoring of blood glucose
- Place in therapy for hypoglycaemic agents
- Interventions should I use to reduce cardiovascular risk
Action: Clinicians involved in the treatment of diabetes will find this MeReC Extra to be useful and informative.